Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company manufactures and sells pharma grade gelatin and di-calcium phosphate, and other pharma products.
Sterling Biotech Limited, also popularly known as Sterling Biotech, is a listed public company incorporated on 23 March, 1985. It is classified as a public limited company and is located in , Maharashtra. It's authorized share capital is INR 2,800.00 cr and the total paid-up capital is INR 643.35 cr.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Nominee Director | Monisha Prabhu Macedo | 00144660 | 1 years |
| Nominee Director | Vishal Jyotindra Gor | 08787850 | 2 years |
| Nominee Director | Keyur Anilkumar Parekh | 08868570 | 2 years |
| Nominee Director | Alok Kumar Garg | 10630493 | 2 years |
| Managing Director | Philip Chacko Mundanilkunnathil | 01219764 | 1 years |
| Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2025 available in Tofler Pro
| Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
State Bank of India
No. of Loans: 1
Total Amount : 22.5 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 14.4 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| MONISHA MACEDO CONSULTANTS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Uttarakhand |
| K P PORTFOLIO PRIVATE LIMITED |
Active
|
1.5 L | 1 | Delhi |
| MINERVA RESOLUTIONS LLP |
Active
|
1.0 Cr | 1 | Delhi |
| INTERISE INVESTMENT MANAGERS LIMITED |
Active
|
56.7 Cr | 1 | |
| DND FLYWAY LIMITED |
Amalgamated
|
50,000.0 | 1 | Delhi |
| IL&FS URBAN INFRASTRUCTURE SERVICES LIMITED |
Amalgamated
|
5.0 L | 1 | Delhi |
| DYERS STONE LIME COMPANY PRIVATE LIMITED |
Active
|
1.5 L | 1 | Delhi |
| VAC INFRA PROJECTS PRIVATE LIMITED |
Strike Off
|
0.0 | 1 | Telangana |
| ZYDUS STRATEGIC INVESTMENTS LIMITED |
Active
|
1.0 Cr | 1 | Gujarat |
| ZYDUS VTEC LIMITED |
Active
|
302.5 Cr | 2 | Gujarat |
| BIOCHEM PHARMACEUTICAL PRIVATE LIMITED |
Active
|
6.0 L | 1 | Gujarat |
| LM MANUFACTURING INDIA PRIVATE LIMITED |
Active
|
5.0 L | 1 | Gujarat |
| ZYDUS MEDTECH PRIVATE LIMITED |
Active
|
160.5 Cr | 1 | Gujarat |
| VISIT HEALTH PRIVATE LIMITED |
Active
|
1.2 Cr | 1 | Delhi |
Read more
The incorporation date of STERLING BIOTECH LIMITED is 23 March, 1985
The authorized share capital of STERLING BIOTECH LIMITED is INR ₹ 2,800.0 Cr.
The paid-up capital of STERLING BIOTECH LIMITED is INR ₹ 643.3 Cr.
The registered address of STERLING BIOTECH LIMITED is Office No. 601, Windfall Building, Sahar Plaza Complex, Near Hotel Kohinoor, (Andheri East), J.B. Nagar, Mumbai, Mumbai, Maharashtra, India, 400059 - 400059
The CIN number of STERLING BIOTECH LIMITED is L51900MH1985PLC035738.